These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31204558)

  • 21. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
    Krzeszinski JY; Wei W; Huynh H; Jin Z; Wang X; Chang TC; Xie XJ; He L; Mangala LS; Lopez-Berestein G; Sood AK; Mendell JT; Wan Y
    Nature; 2014 Aug; 512(7515):431-5. PubMed ID: 25043055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.
    He Y; Rhodes SD; Chen S; Wu X; Yuan J; Yang X; Jiang L; Li X; Takahashi N; Xu M; Mohammad KS; Guise TA; Yang FC
    PLoS One; 2012; 7(11):e46900. PubMed ID: 23144792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss.
    Xu R; Shen X; Xie H; Zhang H; Liu D; Chen X; Fu Y; Zhang P; Yang Y; Cheng J; Jiang H
    Theranostics; 2021; 11(11):5491-5510. PubMed ID: 33859759
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
    Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
    Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
    Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osthole-loaded N-octyl-O-sulfonyl chitosan micelles (NSC-OST) inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in rats.
    Wang L; Zheng S; Huang G; Sun J; Pan Y; Si Y; Tu P; Xu G; Ma Y; Guo Y
    J Cell Mol Med; 2020 Apr; 24(7):4105-4117. PubMed ID: 32126148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA Bmncr alleviates the progression of osteoporosis by inhibiting RANML-induced osteoclast differentiation.
    Chen RS; Zhang XB; Zhu XT; Wang CS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9199-9206. PubMed ID: 31773670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
    Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
    RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircFOXP1/FOXP1 promotes osteogenic differentiation in adipose-derived mesenchymal stem cells and bone regeneration in osteoporosis via miR-33a-5p.
    Shen W; Sun B; Zhou C; Ming W; Zhang S; Wu X
    J Cell Mol Med; 2020 Nov; 24(21):12513-12524. PubMed ID: 32996692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation.
    Wang W; Qiao SC; Wu XB; Sun B; Yang JG; Li X; Zhang X; Qian SJ; Gu YX; Lai HC
    Cell Death Dis; 2021 Jun; 12(7):628. PubMed ID: 34145224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.
    Sun Y; Liu Y; He W; Wang C; Tickner J; Kuek V; Zhou C; Wang H; Zou X; Hong Z; Yang F; Shao M; Chen L; Xu J
    J Cell Physiol; 2019 Jul; 234(7):11792-11804. PubMed ID: 30515822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
    Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
    PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3.
    Zhang Y; Zhang S; Wang Y; Yang Z; Chen Z; Wen N; Yang M; Huang Z; Xie Y; Cai L
    Oxid Med Cell Longev; 2021; 2021():2896674. PubMed ID: 34820053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.